Trials / Unknown
UnknownNCT00999505
Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia
A Double-blind, Randomized, Placebo-controlled Trial With Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Amantadine as add-on therapy to antipsychotics may improve schizophrenia positive, negative and cognitive symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amantadine | Amantadine 200mg twice a day over 12 weeks |
| DRUG | Placebo | Placebo capsules twice a day over 12 weeks |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2009-10-21
- Last updated
- 2011-02-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00999505. Inclusion in this directory is not an endorsement.